Home › Heart Attack › New Jersey
Heart Attack clinical trials in New Jersey
5 studies for Heart Attack are looking for participants at sites in New Jersey.
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Hypertension & Nephrology Association, Eatontown
- New Jersey Kidney Care, Jersey City
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- The Valley Hospital, Ridgewood
- Overlook Medical Center, Summit
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Sep 4, 2026 · NCT07517263OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Advanced Heart Care LLC, Bridgewater
- Advanced Heart and Vascular Institute of Hunterdon, Flemington
- Clinical Reseach Philadelphia Pennington, Hamilton
- and 7 more
RecruitingPhase 3
Ages 50 to 105 · All sexes · Updated Aug 21, 2026 · NCT07136012AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
- Hackensack University Medical Center, Hackensack
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Jun 1, 2026 · NCT06699056Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- Rutgers University, Newark
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Mar 24, 2026 · NCT04774159From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.